We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under... Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma. Show more
- Presentations to be webcast on www.exelixis.com - Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the companyβs management team will participate in fireside chats at the following inve...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.835 | 3.7385269756 | 22.335 | 23.42 | 22.235 | 2927477 | 22.80745928 | CS |
4 | 2.72 | 13.3007334963 | 20.45 | 23.42 | 20.43 | 2537616 | 22.10970328 | CS |
12 | -0.83 | -3.45833333333 | 24 | 24.34 | 19.2 | 2329002 | 22.07534694 | CS |
26 | 1.33 | 6.08974358974 | 21.84 | 24.34 | 18.64 | 2286368 | 21.76132552 | CS |
52 | 5.05 | 27.8697571744 | 18.12 | 24.34 | 17.9 | 2418957 | 20.70968722 | CS |
156 | 0.13 | 0.564236111111 | 23.04 | 25.77 | 14.87 | 2329824 | 19.57074716 | CS |
260 | -1.53 | -6.19433198381 | 24.7 | 27.9 | 13.67 | 2484546 | 20.11313078 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |